Toll-like receptor-MyD88 and Fc receptor pathways of mast cells mediate the thyroid dysfunctions observed during nonthyroidal illness

Proceedings of the National Academy of Sciences of the United States of America

Volumn 104, Issue 14, 2007, Pages 6019-6024

  Rocchi, Roberto ^a   Kimura, Hiroaki ^a   Tzou, Shey Cherng ^a   Suzuki, Koichi ^b   Rose, Noel R ^a   Pinchera, Aldo ^c   Ladenson, Paul W ^a   Caturegli, Patrizio ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c UNIVERSITY OF PISA   (Italy)

Author keywords

Hypothyroidism; Innate immunity euthyroid sick syndrome; Mastocyte

Indexed keywords

ADAPTOR PROTEIN; FC RECEPTOR; IMMUNOGLOBULIN; LIOTHYRONINE; LIPOPOLYSACCHARIDE; MYELOID DIFFERENTIATION FACTOR 88; THYROTROPIN; TOLL LIKE RECEPTOR; FREUND ADJUVANT; IMMUNOLOGICAL ADJUVANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; BONE MARROW; CONTROLLED STUDY; CRYSTALLIZATION; ESCHERICHIA COLI; EUTHYROID SICK SYNDROME; HYPOTHALAMUS HYPOPHYSIS THYROID SYSTEM; HYPOTHYROIDISM; INNATE IMMUNITY; MAST CELL; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THYROID DISEASE; THYROID FUNCTION; WILD TYPE; ANIMAL; BONE MARROW CELL; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; COHORT ANALYSIS; CYTOLOGY; FEMUR; GENETICS; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOPHYSIOLOGY; TIBIA;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MURINAE; MUS; MYCOBACTERIUM TUBERCULOSIS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; COHORT STUDIES; FEMUR; FREUND'S ADJUVANT; HYPOTHYROIDISM; IMMUNITY, NATURAL; LIPOPOLYSACCHARIDES; MAST CELLS; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; MYELOID DIFFERENTIATION FACTOR 88; RECEPTORS, FC; THYROID DISEASES; TIBIA;

EID: 34347253595     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0701319104     Document Type: Article

References (35)

1. De Groot LJ (2006) Crit Care Clin 22:57-86.
2. Fliers E, Alkemade A, Wiersinga WM (2001) Best Pract Res Clin Endocrinol Metab 15:453-464.
3. Faber J, Thomsen HF, Lumholtz IB, Kirkegaard C, Siersbaek-Nielsen K, Friis T (1981) J Clin Endocrinol Metab 53:978-984.
4. Doctor R, Krenning EP, de Jong M, Hennemann G (1993) Clin Endocrinol (Oxford) 39:499-518.
5. Kaptein EM, Robinson WJ, Grieb DA, Nicoloff JT (1982) J Clin Invest 69:526-535.
6. Wilcox RB, Nelson JC, Tomei RT (1994) Eur J Endocrinol 131:9-13.
7. Fekete C, Gereben B, Doleschall M, Harney JW, Dora JM, Bianco AC, Sarkar S, Liposits Z, Rand W, Emerson C, et al. (2004) Endocrinology 145:1649-1655.
8. Fliers E, Guldenaar SE, Wiersinga WM, Swaab DF (1997) J Clin Endocrinol Metab 82:4032-4036.
9. Lechan RM, Fekete C (2004) J Endocrinol Invest 27:105-119.
10. Romijn JA, Wiersinga WM (1990) J Clin Endocrinol Metab 70:35-42.
11. De Jongh FE, Jobsis AC, Elte JW (2001) Eur J Endocrinol 144:221-226.
12. DeGroot LJ (2003) J Endocrinol Invest 26:1163-1170.
13. Stathatos N, Levetan C, Burman KD, Wartofsky L (2001) Best Pract Res Clin Endocrinol Metab 15:465-478.
14. Richardson RP, Rhyne CD, Fong Y, Hesse DG, Tracey KJ, Marano MA, Lowry SF, Antonacci AC, Calvano SE (1989) Ann Surg 210:239-245.
15. van der Poll T, Lowry SF (1995) in Modulation of Inflammatory Response in Severe Sepsis, eds Tellado JM, Forse RA, Solomkin JS (Karger, New York), Vol 20, pp 18-32.
16. van der Poll T, Van Zee KJ, Endert E, Coyle SM, Stiles DM, Pribble JP, Catalano MA, Moldawer LL, Lowry SF (1995) J Clin Endocrinol Metab 80:1341-1346.
17. Boelen A, Platvoet-ter Schiphorst MC, Bakker O, Wiersinga WM (1995) J Endocrinol 146:475-483.
18. Boelen A, Kwakkel J, Platvoet-ter Schiphorst M, Baur A, Kohrle J, Wiersinga WM (2004) Horm Metab Res 36:101-106.
19. Boelen A, Kwakkel J, Platvoet-ter Schiphorst M, Mentrup B, Baur A, Koehrle J, Wiersinga WM (2004) Eur J Endocrinol 151:497-502.
20. Galli SJ, Maurer M, Lantz CS (1999) Curr Opin Immunol 11:53-59.
21. Marshall JS (2004) Nat Rev Immunol 4:787-799.
22. Matsushima H, Yamada N, Matsue H, Shimada S (2004) J Immunol 173:531-541.
23. Wolters PJ, Mallen-St Clair J, Lewis CC, Villalta SA, Baluk P, Erie DJ, Caughey GH (2005) Clin Exp Allergy 35:82-88.
24. Benoist C, Mathis D (2002) Nature 420:875-878.
25. Kulka M, Metcalfe DD (2006) Mol Immunol 43:1579-1586.
26. Jolles S, Hughes J (2006) Int Immunopharmacol 6:579-591.
27. Boelen A, Platvoet-ter Schiphorst MC, van Rooijen N, Wiersinga WM (1996) Eur J Endocrinol 134:513-518.
28. Boelen A, Kwakkel J, Thijssen-Timmer DC, Alkemade A, Fliers E, Wiersinga WM (2004) J Endocrinol 182:315-323.
29. Boelen A, Maas MA, Lowik CW, Platvoet MC, Wiersinga WM (1996) Endocrinology 137:5250-5254.
30. van Buul-Offers S, Hackeng WH, Schopman W (1983) Acta Endocrinol 102:396-409.
31. Chanoine JP, Braverman LE, Farwell AP, Safran M, Alex S, Dubord S, Leonard JL (1993) J Clin Invest 91:2709-2713.
32. Schneider MJ, Fiering SN, Pallud SE, Parlow AF, St Germain DL, Galton VA (2001) Mol Endocrinol 15:2137-2148.
33. Rocchi R, Kunavisarut T, Ladenson PW, Caturegli P (2006) Thyroid 16:705-706.
34. Schueller E, Peutsch M, Bohacek LG, Gupta RK (1967) Can J Med Technol 29:137-138.
35. Pohlenz J, Maqueem A, Cua K, Weiss RE, Van Sande J, Refetoff S (1999) Thyroid 9:1265-1271.